News & Perspective

Jun 21, 2018

Jun 21, 2018

News Scan for Jun 21, 2018

More suspected DRC Ebola
ACIP on flu, anthrax vaccines
US food outbreak review

May 23, 2018

May 23, 2018

News Scan for May 23, 2018

More Nipah in India
Lassa vaccine partnership
Seasonal flu economic burden
Anthrax prophylaxis guidance
Infrared Zika detection

Mar 01, 2018

Mar 01, 2018

News Scan for Mar 01, 2018

Low flu VE in Europe
Novavax flu vaccine trial
Avian flu outbreaks
Public health spending report card
Biodefense caucus forms

Jan 05, 2016

Jan 05, 2016

News Scan for Jan 05, 2016

MCR-1 in Canada
Medical countermeasures for kids
Impact of minor flu strains

Nov 23, 2015

Nov 23, 2015

News Scan for Nov 23, 2015

BioWatch capabilities
Flu vaccine protection
More chikungunya cases
Malaria funding
Cholera in Iraq

May 14, 2015

May 14, 2015

News Scan for May 14, 2015

MERS muddle in Saudi Arabia
H7N9 cases in China
Smallpox vaccine trials
Flu vaccine plant OK'd
Polio vaccination

Oct 03, 2013

Oct 03, 2013

Flu Scan for Oct 03, 2013

H3N2v shedding in ferrets
RNA-based drug development

Oct 06, 2011

Oct 06, 2011

BARDA: Many biodefense products to mature within 5 years

(CIDRAP News) – In releasing a new 5-year strategic plan yesterday, the federal agency tasked with developing new medical countermeasures (MCMs) for bioterrorist attacks and emerging diseases said many such products will be ready for regulatory review within the next 5 years.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»